Skip to content

ESD Home

TechCentury

Powered by

Engineering Society of Detroit Lawrence Technological University

Tag: Cholesterol

Clinical Trials / Pharmaceuticals

Esperion sees positive results from final study on cholesterol-buster

ANN ARBOR — Esperion Therapeutics Inc. (Nasdaq: ESPR), the Ann Arbor-based pharmaceutical developer, announced positive results from the final Phase 3 test of its lead drug candidate, bempedoic acid. The …

TechCentury
Advertise or Contribute an Article
Lawrence Technological University
MITechNews.com

Subscribe to TechCentury.com

Top Posts

  • LTU’s Centrepolis Accelerator named top 2019 project in Southfield Excellence Awards
  • Dura Automotive gets $84M financing
  • Liquid Web Bought Out By Chicago Firm; Founding CEO To Step Down
  • Compuware to acquire New Jersey data protection firm
  • Battery firm emerges from stealth, buys high-voltage business from Bosch

Archives

Follow Us On

© The Engineering Society of Detroit   |   ABOUT